Terug
33
Ook genoteerd als
SONVF
OTC
Dagbereik
€ 42,39
€ 43,80
52-Weeksbereik
€ 42,39
€ 68,76
Volume
9.206
50D / 200D Gem.
€ 52,03
/
€ 54,86
Vorige Slotkoers
€ 44,79
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 23,7 | 0,4 |
| P/B | 4,8 | 2,9 |
| ROE % | 21,1 | 3,8 |
| Net Margin % | 14,0 | 3,9 |
| Rev Growth 5Y % | 10,4 | 10,0 |
| D/E | 0,7 | 0,2 |
Belangrijkste Punten
Revenue grew 10,40% annually over 5 years — strong growth
Earnings declined -10,07% over the past year
ROE of 21,05% indicates high profitability
Generating 656,10M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 3,82%
Cash machine — converts 121,39% of earnings into free cash flow
Groei
Revenue Growth (5Y)
10,40%
Revenue (1Y)6,58%
Earnings (1Y)-10,07%
FCF Growth (3Y)3,79%
Kwaliteit
Return on Equity
21,05%
ROIC11,73%
Net Margin13,98%
Op. Margin17,90%
Veiligheid
Debt / Equity
0,66
Current Ratio1,27
Interest Coverage26,11
Waardering
P/E Ratio
23,66
P/B Ratio4,80
EV/EBITDA20,04
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6,58% | Revenue Growth (3Y) | 1,68% |
| Earnings Growth (1Y) | -10,07% | Earnings Growth (3Y) | -8,64% |
| Revenue Growth (5Y) | 10,40% | Earnings Growth (5Y) | -1,79% |
| Profitability | |||
| Revenue (TTM) | 3,87B | Net Income (TTM) | 540,50M |
| ROE | 21,05% | ROA | 9,12% |
| Gross Margin | 72,04% | Operating Margin | 17,90% |
| Net Margin | 13,98% | Free Cash Flow (TTM) | 656,10M |
| ROIC | 11,73% | FCF Growth (3Y) | 3,79% |
| Safety | |||
| Debt / Equity | 0,66 | Current Ratio | 1,27 |
| Interest Coverage | 26,11 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 23,66 | P/B Ratio | 4,80 |
| P/S Ratio | 3,31 | PEG Ratio | -2,90 |
| EV/EBITDA | 20,04 | Dividend Yield | 0,02% |
| Market Cap | 12,79B | Enterprise Value | 13,86B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,87B | 3,63B | 3,74B | 3,36B | 2,60B |
| Net Income | 540,50M | 601,00M | 647,50M | 649,00M | 581,00M |
| EPS (Diluted) | 1,81 | 2,01 | 2,14 | 2,07 | 1,84 |
| Gross Profit | 2,78B | 2,62B | 2,59B | 2,42B | 1,84B |
| Operating Income | 691,90M | 669,90M | 761,80M | 785,10M | 559,20M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5,92B | 5,79B | 5,55B | 5,59B | 5,93B |
| Total Liabilities | 3,24B | 3,30B | 3,32B | 3,16B | 3,15B |
| Shareholders' Equity | 2,66B | 2,47B | 2,21B | 2,41B | 2,75B |
| Total Debt | 1,76B | 1,79B | 1,81B | 1,48B | 1,83B |
| Cash & Equivalents | 686,90M | 513,60M | 413,90M | 610,50M | 1,77B |
| Current Assets | 1,91B | 1,65B | 1,51B | 1,66B | 2,62B |
| Current Liabilities | 1,50B | 1,14B | 1,10B | 1,51B | 1,25B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#753 of 1024
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026